CD4 and non-small cell lung carcinoma: In another NSCLC study, higher percentages of peripheral CD4+CD62Llow T cells (with a Th1 profile) pretreatment were strikingly associated with response to PD-1 blockade, whereas CD25+FOXP3+CD4+ T cells were increased in non-responders.